主动脉疾病中心

Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial

Proportion of patients with sac regression at 1 year, defined in accordance with SVS guidelines as the reduction in maximum diameter by >= 5 mm when compared to the first CT imaging study obtained within 90 days after index proced...

招聘

DFC 004 Biomarkers for Active Diabetic Foot Ulcers

Proportion of participants with complete wound healing by week 52, defined as complete wound closure where there is skin re-epithelialization without drainage or dressing requirements at two consecutive study visits 2 weeks apart.

招聘

PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Lim...

Freedom from major (above-ankle) amputation and death (all-cause mortality)

招聘

Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm

招聘

Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial

的 primary outcome is the composite of 中风 plus death within 44 days after randomization and ipsilateral 中风 thereafter up to 4 years.

招聘

Post-approval Study of Transcarotid Artery Revascularization in Standard Risk 病人 With Sig...

Hierarchical composite of Major Adverse Events (MAEs) defined as any death, 中风, or myocardial infarction within 30 days of the index procedure

招聘

分支主动脉弓研究

招聘

Adjunct Collection of Additional Biorepository Data From 病人 Enrolled in Diabetic Foot Con...

Proportion of participants consenting to participation in the biorepository from among DFC studies, 通过研究和整体

招聘

BGC101 (EnEPC) Autologous Cell 的rapy From Patient's Own Blood for Treatment of Critical Limb ...

Incidence and proportion of incidence between treatment arms of adverse events of specific interest (AESI) and injection-related AE Incidence of serious adverse events (SAEs) including SAEs related or probably related to the treat...

招聘

C-myc Biomarker Study for Diabetic Foot Ulcers

招聘